Axplora Group GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Axplora Group GmbH - overview
Established
1995
Location
Bavaria, -, Germany
Primary Industry
Pharmaceuticals
About
Founded in 1995 and based in Bavaria, Germany, Axplora Group GmbH specializes in the production of active pharmaceutical ingredients. In September 2021, Novasep Holding SAS, a portfolio company of Bpifrance Investissement Régions, merged with PharmaZell GmbH, a portfolio company of Bridgepoint, to form Axplora Group GmbH. As of 2025, the company is led by its CEO, Martin Meeson. Axplora specializes in the development and manufacturing of active pharmaceutical ingredients (APIs) with a focus on sustainable and technologically advanced solutions.
The company offers a range of services that includes API manufacturing, ADC (antibody-drug conjugates) production, and API (HPAPI) manufacturing. These products are essential in the pharmaceutical industry, providing critical components for therapies that address various health conditions. Axplora collaborates with over 900 customers spanning multiple sectors, including biotech and pharmaceutical firms. The company generates its revenue through direct partnerships and collaborations with pharmaceutical and biotech companies, providing tailored solutions for API production and related services.
Current Investors
Bridgepoint Group, Bpifrance Investissement Régions, PharmaZell GmbH
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.axplora.com/
Verticals
Manufacturing
Company Stage
Merged
Total Amount Raised
Subscriber access only
Axplora Group GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | Novasep Holding SAS | - | ||||||||
| Merger | Completed | Axplora Group GmbH | - | ||||||||
| Merger | Completed | PharmaZell GmbH | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.